The pituitary neuropeptide oxytocin promotes social behavior, and is a potential adjunct
therapy for social deficits in schizophrenia and autism. Oxytocin may mediate pro-social …

Early life adversity can set the trajectory for later psychiatric disorders, including substance
use disorders. There are a host of neurobiological factors that may play a role in the …

The oxytocinergic system promotes social behavior and reduces anxiety. The significant
roles and functional interactions of the medial prefrontal cortex and the amygdala in the …

The neuropeptide oxytocin has emerged as a promising pharmacotherapy for
methamphetamine (METH) addiction, and clinical trials of intranasal oxytocin are underway …

The neuropeptide oxytocin interacts with mesolimbic dopamine neurons to mediate reward
associated with filial behaviors, but also other rewarding behaviors such as eating or taking …

The psychostimulant methamphetamine (METH) is an addictive illicit drug. Systemic
administration of the neuropeptide oxytocin modulates METH‐related reward and METH …

Methamphetamine (METH) abuse is characterised by chronic relapse and anxiety, for which
there are no effective pharmacotherapies. Acute treatment with the neuropeptide oxytocin …

Cue-induced drug craving and seeking progressively increases during abstinence. This
“incubation of drug craving” phenomenon has been observed in both laboratory animals …

Oxytocin (OT), a neurohypophyseal neuropeptide, affects adaptive processes of the central
nervous system. In the present study, we investigated the effects of OT on extracellular levels …

Early life trauma is strongly associated with an increased vulnerability to abuse illicit drugs
and the impairment of neural development. This includes alterations to the development of …